Effects of induced mast cell activation on prostaglandin E and metalloproteinase production by rheumatoid synovial tissue in vitro

Annals of the Rheumatic Diseases

Volumn 57, Issue 1, 1998, Pages 25-32

  Tetlow, L C ^a   Harper, N ^a   Dunningham, T ^b   Morris, M A ^c   Bertfield, H ^d   Woolley, D E ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b TAMESIDE GENERAL HOSPITAL   (United Kingdom)

^c Devonshire Royal Hospital   (United Kingdom)

^d WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; GELATINASE A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MATRIX METALLOPROTEINASE; METALLOPROTEINASE; PROSTAGLANDIN E2; STROMELYSIN; TRYPTASE;

ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SYNTHESIS; EXPLANT; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOLOGY; INFLAMMATION; MAST CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN LOCALIZATION; RADIOIMMUNOASSAY; RHEUMATOID ARTHRITIS; SYNOVIUM;

EID: 0031899639     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.57.1.25     Document Type: Article

References (36)

1. Tetlow LC, Wodlley DE. Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalisation studies. Ann Rheum Dis 1995;54:896-903.
2. Gruber BL, Kaplan AP. Mast cells and rheumatic diseases. In: McCarty DJ, Koopman WJ, eds. Arthritis and allied conditions. 12th ed. Philadelphia: Lea and Febiger, 1993: 417-29.
3. Woolley DE, Tetlovv LC. Observations on the microenvironmental nature of cartilage degradation in rheumatoid arthritis. Ann Rheum Dis 1997;56:151-61.
4. Verbsky JW, McAllister PK, Malone DG. Mast cell activation in human synovium explants by calcium ionophore A23187, compound 48/80, and rabbit IgG anti-human IgG, but not morphine sulphate. Inflamm Res 1996;45:35-41.
5. Woolley DE. Mast cells in the rheumatoid lesion - ringleaders or innocent bystanders? Ann Rheum Dis 1995;54: 533-4.
6. Galli SJ. New concepts about the mast cell. N Engl J Med 1993;328:257-65.
7. Church MK, Caulfield JP. Mast cell and basophil functions. In: Holgate ST, Chruch MK, eds. Allergy. London: Gower Medical, 1993: 51-12.
8. Schwartz LB. Mast cells: function and contents. Curr Opin Immunol 1994;6:91-7.
9. Tetlow LC, Woolley DE. Distribution, activation and tryptase chymase phenotype of mast cells in the rheumatoid lesion. Ann Rheum Dis 1995;4:549-55.
10. Bromley M, Fisher WD, Woolley DE. Mast cells at sites of cartilage erosion in the rheumatoid joint. Ann Rheum Dis 1984;43:76-9.
11. Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, De Carlo A, et al. Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 1993;4:197-250.
12. Murphy G, Docherty AJP, Hembry RM, Reynolds JJ. Metalloproteinases and tissue damage. Br J Rheumatol 1991;30:25-31.
13. Tetlow LC, Woolley DE. Comparative immunolocalisation studies of collagenase 1 and collagenase 3 production in the rheumatoid lesion, and by human chondrocytes and synoviocytes in vitro. Br J Rheumatol (in press).
14. Bonassar LJ, Frank MH, Murray JC, Paguio CG, Moore VL, Lark MW, et al. Changes in cartilage composition and physical properties due to stromelysin degradation. Arthritis Rheum 1995;38:173-83.
15. Wu JJ, Lark MW, Chun LE, Eyre DR. Sites of stromelysin cleavage in collagen types II, IX, X and XI of cartilage. J Biol Chem 1991;266:5625-8.
16. Arend WP, Dayer J-M. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor a in rheumaotid arthritis. Arthritis Rheum 1995;38:151-60.
17. Chu CQ, Field M, Allard S, Abney E, Feldmann M, Maini RN. Detection of cytokines at the cartilage-pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair. BrJ Rheumatol 1992;31:653-61.
18. Gordon JR, Galli SJ. Mast cells as a source of both preformed and immunologically inducible TNF-a/ cachetin. Nature 1990;346:274-6.
19. Galli SJ, Gordon JR, Wershil BK. Cytokine production by mast cells and basophils. Curr Opin Immunol 1991;3:865-73.
20. Yoffe JR, Taylor DJ, Woolley DE. Mast cell products and heparin stimulate the production of mononuclear-cell factor by cultured human monocyte-macrophages. Biochem J 1085;230:83-8.
21. Yoffe JR, Taylor DJ, Woolley DE. Mast cell products stimulate collagenase and prostaglandin E production by cultures of rheumatoid synovial cells. Biochem Biophys Res Comm 1084;122:270-6.
22. Gruber BL, Marchese MJ, Suzuki K, Schwartz LB, Okada Y, Nagase H, et al. Synovial procollagenase activation by human mast cell tryptase: dependence upon matrix metalloproteinase 3 activation. J Clin Invest 1989;84:1657-62.
23. Lees M, Taylor DJ, Woolley DE. Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B. Eur J Biochem 1994;223: 171-7.
24. Suzuki K, Lees M, Newlands GFJ, Nagase H, Woolley DE. Activation of precursors for matrix metalloproteinases 1 (collagenase) and 3 (stromelysin) by rat mast cell proteinases I and II. Biochem J 1995;305:301-6.
25. Norrby K, Woolley DE. Role of mast cells in mitogenesis and angiogenesis in normal tissue and tumour tissue. In: Garcia-Caballero M, Brandes LJ, Hosoda S, eds. Advances in the biosciences. Vol 89. Oxford: Pergamon Press, 1993:71-116.
26. Tetlow LC, Lees M, Woolley DE. Comparative studies of collagenase and stromelysin-1 expression by rheumatoid synoviocytes in vitro. Virchows Archiv 1995;425:569-76.
27. Gruber B, Poznansky M, Boss E, Partin J, Gorevic P, Kaplan AP. Characterization and functional studies of rheumatoid synovial mast cells. Activation by secretagogues. anti-IgE and a histamine-releasing lymphokine. Arthritis Rheum 1986;29:944-55.
28. Kopicky-Burd JA, Kagey-Sabotka A, Peters SP, Dvorak AM, Lennox DW, Lichtenstein LM. Characterization of human synovial mast cells. J Rheumatol 1988;15:1326-33.
29. Bridges AJ, Malone DJ, Jicinsky J, Chen M, Ory P, Engber W, et al. Human synovial mast cell involvement in rheumatoid arthritis and osteoarthritis. Arthritis Rheum 1991;34: 1116-24.
30. Malone DG, Verbsky JW, Dolan PW. A lavage method for dynamic intraarticular monitoring of animal joints in situ: quantification and release kinetics of histamine after selective synovial mast cell activation by diverse secretagogues. J Lab Clin Med 1991;188:260-79.
31. Alter SC, Metcalfe DD, Bradford TR, Schwartz LB. Regulation of human mast cell tryptase. Biochem J 1987;248: 821-7.
32. Subbao-Rao PV, Friedman MM, Atkins FM, Metcalfe DD. Phagocytosis of mast cell granules by cultured fibroblasts. J Immunol 1983;130:341-9.
33. Baggiolini M, Horisberger U, Martin U. Phagocytosis of mast cell granules by mononuclear phagocytes, neutrophils and eosinophils during anaphylaxis. Int Arch Allergy Appl Immunol 1982;67:219-26.
34. Jeziorska M, Salamonsen CA, Woolley DE. Mast cell and eosinophil distribution and activation in human endometrium throughout the menstrual cycle. Biol Reprod 1995;53:312-20.
35. 11 subset with matrix turnover and clinical progression. Arthritis Rheum 1997;40:479-89.
36. de Paulis A, Ciccarelli A, Marino I, de Crescenzo G, Marino D, Marone G. Human synovial mast cells. II. Heterogeneity of the pharmacologic effects of antimflammatory and immunosuppressive drugs. Arthritis Rheum 1997;40:469-78.